| PERIOD ENDING | 31-Dec-97 |
| Total Revenue | 7,440 |
| Cost of Revenue | 4,387 |
|
| Gross Profit | 3,053 |
|
| Operating Expenses |
| Research Development | 834 |
| Selling General and Administrative | 2,117 |
| Non Recurring |
-
|
| Others |
-
|
| |
| Total Operating Expenses |
-
|
|
|
| Operating Income or Loss | 102 |
|
| Income from Continuing Operations |
| Total Other Income/Expenses Net | 784 |
| Earnings Before Interest And Taxes | 886 |
| Interest Expense | 364 |
| Income Before Tax | 522 |
| Income Tax Expense |
-
|
| Minority Interest |
-
|
| |
| Net Income From Continuing Ops | 522 |
|
| Non-recurring Events |
| Discontinued Operations |
-
|
| Extraordinary Items |
-
|
| Effect Of Accounting Changes |
-
|
| Other Items |
-
|
|
|
| Net Income | 522 |
| Preferred Stock And Other Adjustments |
-
|
|
| Net Income Applicable To Common Shares | $522 |
0.51% Nasdaq 
0.06 (1.94%) 
Income Statement
